This study is looking at how a dietary supplement called Weizmannia (Bacillus) coagulans JBI-YZ6.3 affects gut health and constipation in healthy, physically active adults. Researchers want to see if taking this probiotic daily for four weeks can improve constipation symptoms compared to a placebo (an inactive capsule). About 30 men and women between 18 and 50 years old will participate. You might be eligible if you experience daily bloating or bloating for more than 5 days in the past two weeks, and have a BMI between 18.5 and 29.9. The main goal is to measure changes in your constipation score.

Study design

This is a randomized, double-blind, placebo-controlled, crossover study involving about 30 participants. This means you will receive both the active supplement and a placebo at different times, and neither you nor the researchers will know which you are taking at any given time.

What's involved

You will take a capsule daily for two separate 4-week periods, with a 4-week break in between. The total study participation will be about 13 to 14 weeks, including screening and testing visits.

Compensation

Not stated in the trial record.

Follow-up

Your constipation score will be measured at the beginning of the study and at the end of each 4-week supplementation period.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.